Cardiovascular News

29/07/2026

Abbott has initiated the TREAT TR post-market study of the TriClip TEER system for the treatment of tricuspid regurgitation.

Abbott has initiated the TREAT TR post-market study of the TriClip transcatheter edge-to-edge repair (TEER) system for the treatment of tricuspid regurgitation (TR).

29/07/2026

B Braun has announced the enrolment of the first patient in the BASKET BALL trial, an international, randomised, multicentre, open-label trial in patients with coronary artery disease and increased clinical or anatomical risk

B Braun has announced the enrolment of the first patient in the BASKET BALL trial, an international, randomised, multicentre, open-label trial in patients with coronary artery disease and increased clinical or anatomical risk.

06/03/2026

𝗲𝗻𝗩𝗮𝘀𝘁™ 𝗟𝗧𝗕 𝗥𝗲𝘁𝗿𝗶𝗲𝘃𝗲𝗿 𝗮𝘁 𝗖𝗥𝗧 𝗶𝗻 𝗗𝗖: On the heels of 𝗙𝗗𝗔 𝟱𝟭𝟬(𝗸) 𝗰𝗹𝗲𝗮𝗿𝗮𝗻𝗰𝗲 and upcoming 𝗨.𝗦. 𝗹𝗮𝘂𝗻𝗰𝗵 𝗗𝗿. 𝗚𝗮𝘂𝘁𝗮𝗺 𝗞𝘂𝗺𝗮𝗿’𝘀 presentation will highlight how 𝗲𝗻𝗩𝗮𝘀𝘁 — 𝘁𝗵𝗲 𝗳𝗶𝗿𝘀𝘁 𝗮𝗻𝗱 𝗼𝗻𝗹𝘆 𝗹𝗮𝗿𝗴𝗲 𝘁𝗵𝗿𝗼𝗺𝗯𝘂𝘀 𝗯𝘂𝗿𝗱𝗲𝗻 𝗿𝗲𝘁𝗿𝗶𝗲𝘃𝗲𝗿 𝗰𝗹𝗲𝗮𝗿𝗲𝗱 𝘀𝗽𝗲𝗰𝗶𝗳𝗶𝗰𝗮𝗹𝗹𝘆 𝗳𝗼𝗿 𝗰𝗼𝗿𝗼𝗻𝗮𝗿𝘆 𝘁𝗵𝗿𝗼𝗺𝗯𝗲𝗰𝘁𝗼𝗺𝘆 — is designed to 𝗲𝗻𝗰𝗮𝗽𝘀𝘂𝗹𝗮𝘁𝗲 𝗮𝗻𝗱 𝗿𝗲𝗺𝗼𝘃𝗲 𝗰𝗶𝗿𝗰𝘂𝗺𝗳𝗲𝗿𝗲𝗻𝘁𝗶𝗮𝗹 𝗰𝗹𝗼𝘁 with its unique 𝗗𝗿𝗼𝗽 𝗭𝗼𝗻𝗲® 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆, supporting 𝗿𝗮𝗽𝗶𝗱 𝗳𝗹𝗼𝘄 𝗿𝗲𝘀𝘁𝗼𝗿𝗮𝘁𝗶𝗼𝗻 𝗱𝘂𝗿𝗶𝗻𝗴 𝗣𝗖𝗜.

FDA cleared and CE marked. See vesalio.com/envast-ifu/ for indications, safety and warnings.